Bapineuzumab for mild to moderate Alzheimer’s disease: a meta-analysis of randomized controlled trials
Crossref DOI link: https://doi.org/10.1186/s12883-017-0850-1
Published Online: 2017-04-04
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Abushouk, Abdelrahman Ibrahim
Elmaraezy, Ahmed
Aglan, Amro
Salama, Reham
Fouda, Samar
Fouda, Rana
AlSafadi, Ammar M.